Registered entities
Rome Therapeutics, Inc.
Reg. No. 83-3633163United States
Investor mix
15 investors on record; lead investors include Johnson & Johnson, Bristol-Myers Squibb, Eurofarma, LUMA.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 47% |
| Private equity | 1 | 7% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 6 | 40% |